Cargando…
Treatment of Alzheimer’s Disease: Trazodone, Sleep, Serotonin, Norepinephrine, and Future Directions
In this issue, an article by La et al. provides evidence that trazodone delayed cognitive decline in 25 participants with Alzheimer’s disease (AD), mild cognitive impairment, or normal cognition. For participants considered to have AD pathology, trazodone non-users declined at a rate 2.4 times great...
Autor principal: | Ashford, John Wesson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398534/ https://www.ncbi.nlm.nih.gov/pubmed/30776014 http://dx.doi.org/10.3233/JAD-181106 |
Ejemplares similares
-
The Dichotomy of Alzheimer’s Disease Pathology: Amyloid-β and Tau
por: Ashford, J. Wesson
Publicado: (2019) -
Serotonin syndrome associated with sertraline, trazodone and tramadol abuse
por: Nayyar, Neha
Publicado: (2009) -
Tinnitus Treatment with Trazodone
por: Dib, Gabriel Cesar, et al.
Publicado: (2015) -
Advances in screening instruments for Alzheimer's disease
por: Zhou, Xianbo, et al.
Publicado: (2019) -
A Case of Serotonin Syndrome Precipitated by Quetiapine in a Middle-Aged Female on Trazodone and Sertraline
por: Varma, Samyukta, et al.
Publicado: (2022)